Solactive United States Biotechnology Index PR
Master Data
| ISIN: | DE000SL0H894 |
| Bloomberg Ticker: | |
| WKN: | SL0H89 |
Current Quotes
| Last quote (03 Jul 2025): | 2750.46 |
| Day range: | 2750.46 / 2750.46 |
| Change abs./rel.: | 0.00 / 0.00% |
| Year range: | 2385.92 / 3060.24 |
Back to Overview
Please note that the index chart above may be partly comprised of historical performance illustration based on a backtest. The guideline provides an indication where this is the case.
Acquisition | SPRINGWORKS THERAPEUTICS INC | 2nd July 2025
Ordinary Adjustment | Solactive United States Biotechnology Index | Effective Date 23rd June 2025
Acquisition | ACELYRIN INC | 23rd May 2025
Acquisition | 2SEVENTY BIO INC | 13th May 2025
Acquisition | INTRA-CELLULAR THERAPIES INC | 3rd April 2025
Ordinary Adjustment | Solactive United States Biotechnology Index | Effective Date 24th March 2025
Acquisition | REVANCE THERAPEUTICS INC | 10th February 2025
Acquisition | AVID BIOSERVICES INC | 7th February 2025
Acquisition | POSEIDA THERAPEUTICS INC | 8th January 2025
Ordinary Adjustment | Solactive United States Biotechnology Index | Effective Date 23rd December 2024
Acquisition | PETIQ INC | 25th October 2024
Ordinary Adjustment | Solactive United States Biotechnology Index | Effective Date 23rd September 2024
Acquisition | MORPHIC HOLDING INC | 16th August 2024
Acquisition | CEREVEL THERAPEUTICS HOLDINGS INC | 5th August 2024
Acquisition | OLINK HOLDING AB – ADR | 10th July 2024
Spin Off | ILLUMINA INC | 25th June 2024
Acquisition | DECIPHERA PHARMACEUTICALS INC | 13th June 2024
Ordinary Rebalance | Solactive United States Biotechnology Index | Effective Date 24th June 2024
Acquisition | MORPHOSYS AG | 10th June 2024
Acquisition | INHIBRX INC | 30th May 2024
Acquisition | ALPINE IMMUNE SCIENCES INC | 20th May 2024
Acquisition | CYMABAY THERAPEUTICS INC | 22nd March 2024
Acquisition | KARUNA THERAPEUTICS INC | 19th March 2024
Acquisition | AMBRX BIOPHARMA INC | 7th March 2024
Ordinary Rebalance | Solactive United States Biotechnology Index | Effective Date 18th March 2024
Acquisition | RAYZEBIO INC | 28th February 2024
Acquisition | GRACELL BIOTECHNOLOGIES INC | 22nd February 2024
Acquisition | ICOSAVAX INC | 20th February 2024
Acquisition | IMMUNOGEN INC | 14th February 2024
Acquisition | MIRATI THERAPEUTICS INC | 23rd January 2024
Acquisition | ORCHARD THERAPEUTICS PLC | 24th January 2024
Acquisition | POINT BIOPHARMA GLOBAL INC | 29th December 2023
Acquisition | SEAGEN INC | 15th December 2023
Ordinary Rebalance | Solactive United States Biotechnology Index | Effective Date 18th December 2023
Acquisition | ABCAM PLC | 6th December 2023
***UPDATE*** | Acquisition | POINT BIOPHARMA GLOBAL INC | 20th November 2023
Spin Off | ALKERMES PLC | 16th November 2023
Acquisition | INTERCEPT PHARMACEUTICALS INC | 10th November 2023
Acquisition | EQRX INC | 9th November 2023
Acquisition | HORIZON THERAPEUTICS PLC | 6th October 2023
Acquisition | REATA PHARMACEUTICALS INC-A | 26th September 2023
Ordinary Rebalance | Solactive United States Biotechnology Index | Effective Date 18th September 2023
Acquisition | CHINOOK THERAPEUTICS INC | 14th August 2023
Acquisition | DICE MOLECULES HOLDINGS ORD | 9th August 2023
Acquisition | IVERIC BIO INC | 11th July 2023
Acquisition | BELLUS HEALTH INC | 29th June 2023
Acquisition | CTI BIOPHARMA CORP | 26th June 2023
Acquisition | PROMETHEUS BIOSCIENCES INC | 21st June 2023
Ordinary Reweighting | Solactive United States Biotechnology Index | Effective Date 20th June 2023
Acquisition | HESKA CORP | 13th June 2023
Methodology Change | Solactive United States Biotechnology Index | Effective Date 30/05/2023
Market Consultation | Solactive United States Biotechnology Index | May 2023
Acquisition | PROVENTION BIO INC | 1st May 2023
Stock Distribution | AGENUS INC | 26th April 2023
Ordinary Reweighting | Solactive United States Biotechnology Index | Effective Date 20th March 2023